Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Finally, the review addresses the broader implications of these findings for geroscience and outlines future directions for investigating the potential of GLP-1 RAs in healthspan extension, while also acknowledging the limitations and potential biases inherent in this analytical review
Research Insights Superior Weight Loss Outcomes In a 48-week phase 2 study, adults with obesity treated with retatrutide experienced mean weight reductions of 22.8% (8 mg dose) and 24.2% (12 mg dose), outperforming other weight loss medications
Highlights Adults in the U.S
Start Your Online Assessment *Price includes medication only, if prescribed
US$ 22.64
US$ 27.78
US$ 20.18
US$ 26.86
US$ 23.70
US$ 24.29
US$ 27.42
US$ 24.06
US$ 26.04
US$ 25.61
US$ 24.80
US$ 28.33
US$ 20.93
US$ 23.87
US$ 21.29
US$ 24.37
